Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In January 2026, the FDA issued a warning letter to a 503A compounding pharmacy specifically for GLP-1 product violations involving insanitary conditions and strength, quality, and purity noncompliance
50 & Target Kd: 65 pM (HGF) [1] In Vitro Dihexa binds with high affinity to HGF and both dihexa and its parent compound Norleucine 1-AngIV induce c-Met phosphorylation in the presence of subthreshold concentrations of HGF and augment HGF-dependent cell scattering
The following ingredient is doing the exfoliating job in this product: lactobionic acid
The Treatment Process Once your treatment plan is established, youll begin the injection process
US$ 25.39
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 29.92
US$ 25.93
